North America And Australia Silica Market Size, Share & Trends Analysis Report By Application (Oil & Gas, Glass, Food Industry, Foundry Sand, Rubber, Oral Care, Agrochemicals), By Country, And Segment Forecasts, 2025 - 2030

North America And Australia Silica Market Size, Share & Trends Analysis Report By Application (Oil & Gas, Glass, Food Industry, Foundry Sand, Rubber, Oral Care, Agrochemicals), By Country, And Segment Forecasts, 2025 - 2030


North America And Australia Silica Market Growth & Trends

The North America and Australia silica market size is anticipated to reach USD 19.93 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.8% from 2025 to 2030. The market growth is attributed to the rising product demand in various applications including oil & gas, rubber, foundry, glass, agrochemicals, and others. Commercial silica sand obtained through mining mainly finds use in oil & gas, glass, and foundry sand. Speciality silica is extracted through wet and thermal processes and includes precipitated, fumed, and colloidal silica along with silica gel and fused gel. These products undergo different processes and find applications in rubber, agrochemicals, oral care, food, desiccants, paints & coatings, and other applications.

Based on application, the market is segmented into oil & gas, glass, foundry, rubber, agrochemicals, oral care, food, desiccants, paints & coatings, and others. The product demand in the oil & gas industry is expected to increase on account of the rising hydraulic fracturing activities. In addition, high demand for glass products owing to the growth in construction activities and increasing beverages consumption will further drive the market. Moreover, the market is expected to witness lucrative growth opportunities in the rubber industry. Highly dispersible silica is used in green tire production, which further enhances the performance parameters of the tire in terms of fuel efficiency and safety, without affecting the durability of the tire.

This is driving the consumption of silica in countries in North America moving toward high production of green tires. With the outbreak of COVID-19, the production of silica sand was severely impacted as the demand from end-use industries declined significantly in 2020. For example, W. R. Grace & Co.-Conn sales in 2020 decreased by 11.7% as compared to 2019. However, with recovery in the economy and increasing demand from industries, such as oil & gas, glass, rubber, and foundry, the production is expected to increase during the forecast period. The growing demand and low production led to a surge in prices in 2021. For example, in November 2021, U.S. Silica Holdings Inc. announced raise in price for its products in the range of 6% to 14% starting from February 2022.

The price increase is part of the company’s plan to curb losses due to a significant and continuous rise in labor, transportation, materials, and manufacturing costs. The market is highly competitive owing to the presence of numerous players and rising product demand from application industries. For instance, in December 2021, Canadian Premium Sand Inc. (CPS) announced to set up its first solar glass manufacturing facility in North America. The company chose the City of Selkirk, Manitoba as the location due to its proximity to a high-grade silica sand quarry.

North America And Australia Silica Market Report Highlights
  • The oil & gas segment held the largest revenue share in 2024 owing to the increasing number of rigs in North America and growing investments in the Australian oil & gas industry
  • A rise in raw material, energy, and transportation costs during the COVID-19 pandemic impacted final product prices
  • For instance, in August 2021, PQ Corp. announced new prices for its silica products in the U.S. and Canada. The company along with its subsidiary National Silicates declared a price hike of 10–12% for its products
  • Companies in Australia are making efforts to increase the production of silica. For instance, in September 2021, VRX silica started the processing of its second silica sands project at Arrowsmith, Western Australia. The company is currently awaiting environmental approval for its advanced Arrowsmith North project
  • The silica market in Australia is projected to be the fastest-growing in the region over the forecast period. The high market growth is on account of development in the application industries, such as glass and foundry, in the country
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Dosage
1.2.3. Application
1.2.4. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Intranasal Drug and Vaccine Delivery Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Intranasal Drug and Vaccine Delivery Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Powder Delivery Device
4.4.1. Powder Delivery Device Market, 2018 - 2030 (USD Million)
4.5. Liquid Delivery Device (Metered Spray Pumps)
4.5.1. Liquid Delivery Device (Metered Spray Pumps) Market, 2018 - 2030 (USD Million)
4.6. Pressurized Metered Dose Inhaler
4.6.1. Pressurized Metered Dose Inhaler Market, 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Intranasal Drug and Vaccine Delivery Market: Dosage Business Analysis
5.1. Dosage Market Share, 2024 & 2030
5.2. Dosage Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Dosage, 2018 to 2030 (USD Million)
5.4. Unit-dose
5.4.1. Unit-dose Market, 2018 - 2030 (USD Million)
5.5. Multi-dose
5.5.1. Multi-dose Market, 2018 - 2030 (USD Million)
Chapter 6. Intranasal Drug and Vaccine Delivery Market: Application Business Analysis
6.1. Application Market Share, 2024 & 2030
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Respiratory Disorders
6.4.1. Respiratory Disorders Market, 2018 - 2030 (USD Million)
6.5. Neurological Disorders
6.5.1. Neurological Disorders Market, 2018 - 2030 (USD Million)
6.6. Vaccination
6.6.1. Vaccination Market, 2018 - 2030 (USD Million)
6.7. Pain Management
6.7.1. Pain Management Market, 2018 - 2030 (USD Million)
6.8. Others
6.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Intranasal Drug and Vaccine Delivery Market: Distribution Channel Business Analysis
7.1. Distribution Channel Market Share, 2024 & 2030
7.2. Distribution Channel Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
7.4. Hospital Pharmacies
7.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
7.5. Retail Pharmacies
7.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
7.6. Online Pharmacies
7.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)
Chapter 8. Intranasal Drug and Vaccine Delivery Market: Regional Estimates & Trend Analysis by Product, Dosage, Application, and Distribution Channel
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
8.4.1. North America Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Regulatory Framework
8.4.2.3. Competitive Insights
8.4.2.4. U.S. Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Regulatory Framework
8.4.3.3. Competitive Insights
8.4.3.4. Canada Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Regulatory Framework
8.4.4.3. Competitive Insights
8.4.4.4. Mexico Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5. Europe
8.5.1. Europe Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Regulatory Framework
8.5.2.3. Competitive Insights
8.5.2.4. UK Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Regulatory Framework
8.5.3.3. Competitive Insights
8.5.3.4. Germany Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Regulatory Framework
8.5.4.3. Competitive Insights
8.5.4.4. France Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Regulatory Framework
8.5.5.3. Competitive Insights
8.5.5.4. Italy Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Regulatory Framework
8.5.6.3. Competitive Insights
8.5.6.4. Spain Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.7. Norway
8.5.7.1. Key Country Dynamics
8.5.7.2. Regulatory Framework
8.5.7.3. Competitive Insights
8.5.7.4. Norway Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.8. Denmark
8.5.8.1. Key Country Dynamics
8.5.8.2. Regulatory Framework
8.5.8.3. Competitive Insights
8.5.8.4. Denmark Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.9. Sweden
8.5.9.1. Key Country Dynamics
8.5.9.2. Regulatory Framework
8.5.9.3. Competitive Insights
8.5.9.4. Sweden Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Regulatory Framework
8.6.2.3. Competitive Insights
8.6.2.4. Japan Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Regulatory Framework
8.6.3.3. Competitive Insights
8.6.3.4. China Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Regulatory Framework
8.6.4.3. Competitive Insights
8.6.4.4. India Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.5. South Korea
8.6.5.1. Key Country Dynamics
8.6.5.2. Regulatory Framework
8.6.5.3. Competitive Insights
8.6.5.4. South Korea Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.6. Australia
8.6.6.1. Key Country Dynamics
8.6.6.2. Regulatory Framework
8.6.6.3. Competitive Insights
8.6.6.4. Australia Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Regulatory Framework
8.6.7.3. Competitive Insights
8.6.7.4. Thailand Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Regulatory Framework
8.7.2.3. Competitive Insights
8.7.2.4. Brazil Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Regulatory Framework
8.7.3.3. Competitive Insights
8.7.3.4. Argentina Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8. MEA
8.8.1. MEA Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Regulatory Framework
8.8.2.3. Competitive Insights
8.8.2.4. South Africa Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Regulatory Framework
8.8.3.3. Competitive Insights
8.8.3.4. Saudi Arabia Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Regulatory Framework
8.8.4.3. Competitive Insights
8.8.4.4. UAE Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Regulatory Framework
8.8.5.3. Competitive Insights
8.8.5.4. Kuwait Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
9.5.1. GSK plc
9.5.1.1. Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. Teva Pharmaceutical Industries Ltd
9.5.2.1. Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3. AptarGroup, Inc.
9.5.3.1. Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic Initiatives
9.5.4. UCB S.A., Belgium
9.5.4.1. Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. Teleflex Incorporated
9.5.5.1. Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.5.4. Strategic Initiatives
9.5.6. 3M
9.5.6.1. Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives
9.5.7. Bespak Limited
9.5.7.1. Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic Initiatives
9.5.8. Optinose
9.5.8.1. Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic Initiatives
9.5.9. Intersect ENT
9.5.9.1. Overview
9.5.9.2. Financial Performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings